Form 8-K - Current report:
SEC Accession No. 0001493152-24-041006
Filing Date
2024-10-15
Accepted
2024-10-15 06:13:51
Documents
13
Period of Report
2024-10-13
Items
Item 1.03: Bankruptcy or Receivership
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38871
  Complete submission text file 0001493152-24-041006.txt   211102

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ntbl-20241013.xsd EX-101.SCH 3024
3 XBRL LABEL FILE ntbl-20241013_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ntbl-20241013_pre.xml EX-101.PRE 24171
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3441
Mailing Address 320 HATCH DRIVE FOSTER CITY CA 94404
Business Address 320 HATCH DRIVE FOSTER CITY CA 94404 415-851-2410
Notable Labs, Ltd. (Filer) CIK: 0001603207 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36581 | Film No.: 241369062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)